
Humana, Inc. Stock Hits Day Low Amid Price Pressure, Reaches $251.16
2025-11-06 16:07:39Humana, Inc. faced a notable stock decline today, reaching an intraday low and reflecting a challenging market environment. Despite a recent net profit report indicating positive momentum, the company's stock has underperformed compared to the S&P 500 over the past year, raising concerns about its valuation metrics.
Read MoreIs Humana, Inc. technically bullish or bearish?
2025-11-05 11:18:13As of 31 October 2025, the technical trend for Humana, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a mildly bullish stance. However, the weekly KST is mildly bearish, and the Bollinger Bands show a mildly bearish signal on the monthly timeframe. The Dow Theory reflects a mildly bullish trend on the weekly basis but shows no trend monthly. In terms of performance, Humana has underperformed the S&P 500 across multiple periods, with a year-to-date return of 11.10% compared to the S&P 500's 16.30%, and a one-year return of 8.12% against the S&P 500's 19.89%. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from various indicators....
Read More
Humana, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators
2025-11-04 15:44:52Humana, Inc. has recently revised its evaluation amid fluctuating market conditions, with its stock showing a slight increase. Over the past year, the company has experienced significant trading activity. Despite some mixed technical indicators, Humana's returns have lagged behind the S&P 500 across various time frames, reflecting ongoing challenges.
Read MoreIs Humana, Inc. technically bullish or bearish?
2025-11-04 11:29:29As of 31 October 2025, the technical trend for Humana, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a mildly bullish stance. However, the Bollinger Bands show a mixed signal with a mildly bullish weekly view and a mildly bearish monthly view. The KST, Dow Theory, and OBV all reflect a mildly bullish stance across both weekly and monthly time frames. In terms of performance, Humana's year-to-date return is 10.33%, which lags behind the S&P 500's 16.30%. Over the past year, Humana has returned 7.37%, again underperforming the S&P 500's 19.89%. Overall, the current technical stance is mildly bullish, but the stock has struggled relative to its benchmark in the longer term....
Read MoreIs Humana, Inc. technically bullish or bearish?
2025-11-03 11:28:23As of 31 October 2025, the technical trend for Humana, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a mildly bullish stance. The KST shows bullish momentum on the weekly and mildly bullish on the monthly. However, the Bollinger Bands present a mixed view with a mildly bullish weekly signal and a mildly bearish monthly signal. The Dow Theory also reflects a mildly bullish trend in both weekly and monthly assessments. In terms of performance, Humana's returns have lagged behind the S&P 500, with a 1-week return of -4.29% compared to the S&P 500's 0.71%, but a stronger 1-month return of 12.73% against the S&P 500's 1.92%. Over the longer term, however, the stock has underperformed significantly, with 3-year and 5-year returns of -50.15% and -30.33%, respectively, compared to the S&P 500's gains. Overa...
Read MoreIs Humana, Inc. technically bullish or bearish?
2025-11-02 11:14:57As of 31 October 2025, the technical trend for Humana, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages also indicate a mildly bullish stance. However, the Bollinger Bands show a mixed signal with weekly mildly bullish and monthly mildly bearish readings. The KST and Dow Theory both reflect a mildly bullish trend on a monthly basis. In terms of performance, Humana has underperformed the S&P 500 over the 1-year, 3-year, and 5-year periods, with returns of 7.90%, -50.15%, and -30.33% respectively, compared to 19.89%, 76.66%, and 109.18% for the index. Overall, the current technical stance is mildly bullish, but the stock's longer-term performance relative to the S&P 500 raises caution....
Read More
Humana, Inc. Hits Day High with Strong 10.56% Intraday Surge
2025-10-06 18:02:24Humana, Inc. has seen a notable increase in its stock performance, reaching an intraday high of USD 287.32. While it has outperformed the S&P 500 recently, the company has faced longer-term challenges. Humana reported a net profit of USD 1,789 million in March 2025 and maintains a strong return on equity.
Read MoreIs Humana, Inc. technically bullish or bearish?
2025-09-20 18:56:01As of 10 September 2025, the technical trend for Humana, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the KST is also bullish, indicating positive momentum. However, the monthly MACD is only mildly bullish, and the Bollinger Bands show a bearish stance on the monthly timeframe. The daily moving averages are mildly bullish, suggesting some short-term strength. Despite the current bullish trend, the stock has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of 4.39% versus the S&P 500's 12.22%, and a one-year return of -15.99% compared to the S&P 500's 17.14%. Overall, the current technical stance is bullish but with caution due to mixed signals in longer timeframes and significant underperformance against the benchmark....
Read MoreIs Humana, Inc. overvalued or undervalued?
2025-09-20 17:27:58As of 30 June 2025, Humana, Inc. has moved from expensive to very expensive, indicating a significant shift in its valuation outlook. The company is considered overvalued, with a P/E ratio of 26, which is substantially higher than its peer Centene Corp., which has a P/E of 6.94. Additionally, Humana's EV to EBITDA stands at 37.39, again reflecting a premium compared to Centene's 11.91, further supporting the overvaluation assessment. The price to book value is 2.48, suggesting that investors are paying a high price relative to the company's net assets. In terms of recent performance, Humana has underperformed compared to the S&P 500, with a 1-year return of -15.99% versus the S&P 500's 17.14%, and a staggering 3-year return of -47.01% compared to the S&P 500's 70.41%. This trend reinforces the notion that the stock is overvalued in the current market context....
Read More





